Dyadic International (DYAI) Gross Profit Growth (1y) (2019 - 2025)
Powered by 
Analysis
Dyadic International (DYAI) Gross Profit Growth (1y) (2019 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.67 Bn | 192.69 Bn | 7.24 Bn | 17.43% |
| 2 | Gilead Sciences | 180.06 Bn | 176.88 Bn | 6.22 Bn | 11.52% |
| 3 | Vertex Pharmaceuticals | 131.44 Bn | 123.59 Bn | 2.84 Bn | 11.24% |
| 4 | Regeneron Pharmaceuticals | 81.94 Bn | 73.95 Bn | 3.93 Bn | 15.59% |
| 5 | Argenx Se | 60.28 Bn | 55.10 Bn | 1.37 Bn | 63.51% |
| 6 | Moderna | 53.87 Bn | 48.73 Bn | 52.00 Mn | 126.09% |
| 7 | Alnylam Pharmaceuticals | 33.15 Bn | 29.85 Bn | 992.69 Mn | 57.16% |
| 8 | Biogen | 31.88 Bn | 30.60 Bn | 1.96 Bn | -3.99% |
| 9 | Roivant Sciences | 29.16 Bn | 29.16 Bn | 1.16 Mn | - |
| 10 | Dyadic International | 18.24 Mn | 10.27 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -49.69% |
| Dec 31, 2024 | 38.09% |
| Sep 30, 2024 | 436.28% |
| Jun 30, 2024 | 89.85% |
| Mar 31, 2024 | -24.08% |
| Dec 31, 2023 | 757.44% |
| Sep 30, 2023 | 5.22% |
| Jun 30, 2023 | -82.13% |
| Mar 31, 2023 | 3.06% |
| Dec 31, 2022 | 313.95% |
| Sep 30, 2022 | -7.87% |
| Jun 30, 2022 | 129.99% |
| Mar 31, 2022 | -99.65% |
| Dec 31, 2021 | -120.30% |
| Sep 30, 2021 | 101.02% |
| Jun 30, 2021 | 207.62% |
| Mar 31, 2021 | 187,471.93% |
| Dec 31, 2020 | -88.38% |
| Sep 30, 2020 | 114.38% |
| Jun 30, 2020 | -245.63% |